embryonic lethality, incomplete penetrance_Hic2<Gt(E225A08)1.2Wrst>/Hic2<Gt(E225A08)1.2Wrst>

http://metadb.riken.jp/0011102I129P2OlaHsdHic2GtE225A0812WrstHic2GtE225A0812WrstHic2GtE225A0812Wrst

embryonic lethality, incomplete penetrance_Hic2<Gt(E225A08)1.2Wrst>/Hic2<Gt(E225A08)1.2Wrst>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• hypermethylated in cancer 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1929869

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Hic2<Gt(E225A08)1.2Wrst>/Hic2<Gt(E225A08)1.2Wrst>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Hic2<Gt(E225A08)1.2Wrst>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• partial embryonic lethality
  http://purl.obolibrary.org/obo/MP_0011102

文献

http://purl.org/net/cito/citesAsAuthority

• Iain M. Dykes, et.al., HIC2 is a novel dosage-dependent regulator of cardiac development located within the distal 22q11 deletion syndrome region., Circulation research, 2014, 115
  http://rdf.ncbi.nlm.nih.gov/pubmed/24748541